Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IQV | Common Stock | Purchase | $3.19K | +13 | +0.06% | $245.32 | 20.4K | Jul 20, 2021 | Direct | |
transaction | IQV | Common Stock | Award | $0 | +5.87K | +28.83% | $0.00 | 26.2K | Feb 10, 2022 | Direct | F1 |
holding | IQV | Common Stock | 11.9K | Jul 20, 2021 | By Trust | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IQV | Stock Appreciation Right | Award | $0 | +21.8K | $0.00 | 21.8K | Feb 10, 2022 | Common Stock | 21.8K | $250.43 | Direct | F3 |
Id | Content |
---|---|
F1 | Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. |
F2 | Shares held in Ronald E. Bruehlman Revocable Trust. |
F3 | The stock appreciation right vests in three annual installments beginning on February 10, 2023. |
EVP & Chief Financial Officer